SCN9A Gene Generalized epilepsy with febrile seizures plus type 7 Genetic Test
Are you concerned about the possibility of having Generalized Epilepsy with Febrile Seizures Plus Type 7 (GEFS+7)? DNA Labs UAE offers a comprehensive genetic test to determine if you have this rare genetic disorder. With a test cost of AED 4400.0, we provide accurate results using the latest NGS Technology.
Test Details
The SCN9A gene is associated with the development of Generalized Epilepsy with Febrile Seizures Plus Type 7 (GEFS+7), a rare genetic disorder characterized by seizures that occur in response to fever. Our NGS Genetic Testing uses next-generation sequencing to analyze the DNA sequence of the SCN9A gene, identifying any mutations that may cause GEFS+7. This test is particularly useful for individuals with a family history of the disorder or those exhibiting symptoms consistent with the condition.
Components and Price
Our SCN9A Gene Generalized epilepsy with febrile seizures plus type 7 Genetic Test is priced at AED 4400.0. The test requires a blood sample or extracted DNA, or just one drop of blood on an FTA Card. The report will be delivered to you within 3 to 4 weeks.
Test Method
We utilize NGS Technology for our genetic testing. Next-generation sequencing allows for a more comprehensive analysis of the SCN9A gene, providing accurate results for our patients.
Test Type and Doctor
This test falls under the category of Neurological Disorders and is conducted by our experienced Neurologist. Our Genetics department specializes in this type of testing, ensuring accurate and reliable results.
Pre Test Information
Before undergoing the SCN9A Gene Generalized epilepsy with febrile seizures plus type 7 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by GEFS+7. This information helps us better understand the genetic implications and provide more accurate results.
Early Diagnosis and Treatment
Early diagnosis of GEFS+7 is crucial for effective management of symptoms and improving the quality of life for affected individuals. By identifying mutations in the SCN9A gene, our genetic test can confirm a diagnosis, allowing for appropriate treatment and support.
Don’t let uncertainty control your life. Contact DNA Labs UAE today to schedule your SCN9A Gene Generalized epilepsy with febrile seizures plus type 7 Genetic Test and gain peace of mind.
| Test Name | SCN9A Gene Generalized epilepsy with febrile seizures plus type 7 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SCN9A Gene Generalized epilepsy with febrile seizures plus type 7 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN9A Gene Generalized epilepsy with febrile seizures plus type 7 |
| Test Details | The SCN9A gene is associated with the development of Generalized Epilepsy with Febrile Seizures Plus Type 7 (GEFS+7), a rare genetic disorder characterized by seizures that occur in response to fever. NGS Genetic Testing is a diagnostic tool that uses next-generation sequencing to analyze the DNA sequence of the SCN9A gene to identify mutations that may cause GEFS+7. This test can help confirm a diagnosis of GEFS+7 in individuals who have a family history of the disorder or who exhibit symptoms consistent with the condition. Early diagnosis and treatment can help manage symptoms and improve the quality of life for individuals with GEFS+7. |
